Market Cap | 670.82K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -750.44k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 9.00% |
Sales | 194.75k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -62.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -97.00% |
Recommedations | - | Quick Ratio | 0.08 | Shares Outstanding | 134.16M | 52W Low Chg | 200.00% |
Insider Own | - | ROA | -124.60% | Shares Float | 124.26M | Beta | -45.71 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00030 |
Gross Margin | 25.45% | Profit Margin | - | Avg. Volume | 3,622 | Target Price | - |
Oper. Margin | -168.52% | Earnings Date | - | Volume | 5,000 | Change | 0.00% |
UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers. Its products are used in hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casinos, and military installations. The company was formerly known as Northwest Chariots Incorporated and changed its name to UV Flu Technologies, Inc. in November 2009. UV Flu Technologies, Inc. was founded in 2006 and is based in Lincolnshire, Illinois.